BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37522199)

  • 21. The prognostic nutritional index predicts survival for patients with extranodal natural killer/T cell lymphoma, nasal type.
    Chen KL; Liu YH; Li WY; Chen J; Gu YK; Geng QR; Jiang WQ; Huang HQ; Lin TY; Xia ZJ; Cai QQ
    Ann Hematol; 2015 Aug; 94(8):1389-400. PubMed ID: 25869028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The prognostic value of preoperative peripheral blood inflammatory biomarkers for intrahepatic cholangiocarcinoma after radical resection].
    Li Q; Zhang R; Fu JL; Zhang J; Su JB; Jin ZC; Chen C; Zhang D; Geng ZM
    Zhonghua Zhong Liu Za Zhi; 2022 Nov; 44(11):1194-1201. PubMed ID: 36380668
    [No Abstract]   [Full Text] [Related]  

  • 23. Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
    Huang JJ; Jiang WQ; Lin TY; Huang Y; Xu RH; Huang HQ; Li ZM
    Ann Oncol; 2011 Jan; 22(1):149-155. PubMed ID: 20595450
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Novel and Validated Inflammation-Based Prognosis Score (IBPS) Predicts Outcomes in Patients with Diffuse Large B-Cell Lymphoma.
    Liu Y; Sheng L; Hua H; Zhou J; Zhao Y; Wang B
    Cancer Manag Res; 2023; 15():651-666. PubMed ID: 37465083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum aspartate aminotransferase, a novel potential biomarker of prognosis in extranodal natural killer/T cell lymphoma, nasal type.
    Yao N; Hou Q; Liang Y; Cao X; Sun B; Wei L; Sun R; Cao J
    Cancer Biomark; 2024; 39(4):265-275. PubMed ID: 38108343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerance of GELOXD/P-GEMOXD in newly diagnosed nasal-type extranodal NK/T-cell lymphoma: A multicenter retrospective study.
    Li JW; Li YJ; Zhong MZ; Liu XL; Li J; Li KL; Liu XY; Zhou F; OuYang Z; Sun ZY; Huang LJ; He JQ; Zhou H; Yi PY
    Eur J Haematol; 2018 Mar; 100(3):247-256. PubMed ID: 29194798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic nomogram for overall survival in upper aerodigestive tract extranodal natural killer/T-cell lymphoma, nasal type, stages IE and IIE: A SEER-based study.
    Wang G; Chang Y; Wu X; Li X; Li L; Zhang M
    Oncol Lett; 2019 Oct; 18(4):3493-3500. PubMed ID: 31516567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of nomogram models of inflammatory markers based on clinical database to predict prognosis for hepatocellular carcinoma after surgical resection.
    Mao S; Yu X; Sun J; Yang Y; Shan Y; Sun J; Mugaanyi J; Fan R; Wu S; Lu C
    BMC Cancer; 2022 Mar; 22(1):249. PubMed ID: 35255845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Construction of a nomogram model for predicting 2-year survival rate of small cell lung cancer based on more comprehensive variables].
    Wei LJ; Hou Q; Yao NN; Liang Y; Cao X; Sun BC; Li HW; Liu JT; Xu SM; Cao J
    Zhonghua Yi Xue Za Zhi; 2022 May; 102(17):1283-1289. PubMed ID: 35488697
    [No Abstract]   [Full Text] [Related]  

  • 30. Two web-based dynamically interactive nomograms and risk stratification systems for predicting survival outcomes and guiding treatment in non-metastatic nasopharyngeal carcinoma.
    Zuo H; Li MM
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15969-15987. PubMed ID: 37684510
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical implication of the advanced lung cancer inflammation index in patients with right-sided colon cancer after complete mesocolic excision: a propensity score-matched analysis.
    Deng Y; Sun Y; Lin Y; Huang Y; Chi P
    World J Surg Oncol; 2022 Aug; 20(1):246. PubMed ID: 35909159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and Validation of Nomograms to Predict the Prognosis of Patients With Unresectable Hepatocellular Carcinoma Receiving Transarterial Chemoembolization.
    Zhao D; Xu W; Zhan Y; Xu L; Ding W; Xu A; Hou Z; Ni C
    Clin Med Insights Oncol; 2023; 17():11795549231178178. PubMed ID: 37378393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Novel Prognostic Score Including the CD4/CD8 for AIDS-Related Lymphoma.
    Chen J; Liu X; Qin S; Ruan G; Lu A; Zhang J; Wu Y; Xie Z; Peng J
    Front Cell Infect Microbiol; 2022; 12():919446. PubMed ID: 35873145
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk factors and survival prediction of young breast cancer patients with liver metastases: a population-based study.
    Pu CC; Yin L; Yan JM
    Front Endocrinol (Lausanne); 2023; 14():1158759. PubMed ID: 37424855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Assessment of Novel Predictive Nomograms Based on APRI for Hepatitis B Virus-associated Small Solitary Hepatocellular Carcinoma with Stereotactic Body Radiotherapy.
    Lai L; Su T; Liang Z; Lu Y; Hou E; Lian Z; Gao H; Zhu X
    J Cancer; 2020; 11(22):6642-6652. PubMed ID: 33046985
    [No Abstract]   [Full Text] [Related]  

  • 37. Preoperative Systemic Immune-Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I-II Gastric Cancer After Radical Surgery.
    He K; Si L; Pan X; Sun L; Wang Y; Lu J; Wang X
    Front Oncol; 2022; 12():829689. PubMed ID: 35296020
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic Nomogram for Overall Survival in Extranodal Natural Killer/T-Cell Lymphoma Patients.
    Li K; Wang R; Huang S; Pan X; Chen H; Zhou L; Wei J; Wu C; Zhu X; Liang S; Qu S
    Clin Lymphoma Myeloma Leuk; 2018 Dec; 18(12):e537-e543. PubMed ID: 30243570
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prognostic value of lymphocyte-to-monocyte ratio in angioimmunoblastic T cell lymphoma].
    Niu JY; Zhu HY; Wang L; Fan L; Liang JH; Cao L; Wu W; Xia Y; Wu JZ; Li JY; Xu W
    Zhonghua Xue Ye Xue Za Zhi; 2018 Apr; 39(4):265-270. PubMed ID: 29779318
    [No Abstract]   [Full Text] [Related]  

  • 40. New biomarkers exploration and nomogram construction of prognostic and immune-related adverse events of advanced non-small cell lung cancer patients receiving immune checkpoint inhibitors.
    Lin X; Chen X; Long X; Zeng C; Zhang Z; Fang W; Xu P
    Respir Res; 2023 Feb; 24(1):64. PubMed ID: 36849947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.